4-in-1 deal: Forma grabs $225m from Celgene

Forma Therapeutics nabbed a $225m upfront fee to enter into its second collaboration with Celgene, but the agreement is structured as up to four transactions in one – the last deal being an acquisition of Forma by its partner.